Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Meissner

Showing results (411-420 of 436) with videos related to

Pageof 44
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2022
The Unified Multiple System Atrophy Rating Scale: Status, Critique, and RecommendationsFlorian Krismer, Jose-Alberto Palma, Giovanna Calandra-Buonaura, et al.
JAMA|February 24, 2015
Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infectionAnu Osinusi, Kerry Townsend, Anita Kohli, et al.
Neurology|October 2, 2019
Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatmentPietro Cortelli, Giovanna Calandra-Buonaura, Eduardo E Benarroch, et al.
Parkinsonism & Related Disorders|April 11, 2021
Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatmentGiovanna Calandra-Buonaura, Enrico Alfonsi, Luca Vignatelli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2023
A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's DiseaseFrancisco Cardoso, Christopher G Goetz, Tiago A Mestre, et al.
Journal of Neurology|August 30, 2023
Volumetric changes and clinical trajectories in Parkinson's disease: a prospective multicentric studyAna Marques, Elise Macias, Bruno Pereira, et al.
JAMA|August 29, 2013
Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trialAnuoluwapo Osinusi, Eric G Meissner, Yu-Jin Lee, et al.
Neurology|October 19, 2012
FXTAS: new insights and the need for revised diagnostic criteriaEmmanuelle Apartis, Anne Blancher, Wassilios G Meissner, et al.
Journal of Medicinal Chemistry|February 16, 2017
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase KinasePaul A Brough, Lisa Baker, Simon Bedford, et al.
CNS Drugs|May 25, 2025
Motor and Non-motor Complications Following Different Early Therapies in Parkinson's Disease: Longitudinal Analysis of Real-Life Clinical and Therapeutic Data from the French NS-PARK CohortAymeric Lanore, Edouard Januel, Nathalie Bertille, et al.
Pageof 44

Showing results (411-420 of 436) with videos related to

Sort By:
Pageof 44
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2022
The Unified Multiple System Atrophy Rating Scale: Status, Critique, and RecommendationsFlorian Krismer, Jose-Alberto Palma, Giovanna Calandra-Buonaura, et al.
JAMA|February 24, 2015
Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infectionAnu Osinusi, Kerry Townsend, Anita Kohli, et al.
Neurology|October 2, 2019
Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatmentPietro Cortelli, Giovanna Calandra-Buonaura, Eduardo E Benarroch, et al.
Parkinsonism & Related Disorders|April 11, 2021
Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatmentGiovanna Calandra-Buonaura, Enrico Alfonsi, Luca Vignatelli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2023
A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's DiseaseFrancisco Cardoso, Christopher G Goetz, Tiago A Mestre, et al.
Journal of Neurology|August 30, 2023
Volumetric changes and clinical trajectories in Parkinson's disease: a prospective multicentric studyAna Marques, Elise Macias, Bruno Pereira, et al.
JAMA|August 29, 2013
Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trialAnuoluwapo Osinusi, Eric G Meissner, Yu-Jin Lee, et al.
Neurology|October 19, 2012
FXTAS: new insights and the need for revised diagnostic criteriaEmmanuelle Apartis, Anne Blancher, Wassilios G Meissner, et al.
Journal of Medicinal Chemistry|February 16, 2017
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase KinasePaul A Brough, Lisa Baker, Simon Bedford, et al.
CNS Drugs|May 25, 2025
Motor and Non-motor Complications Following Different Early Therapies in Parkinson's Disease: Longitudinal Analysis of Real-Life Clinical and Therapeutic Data from the French NS-PARK CohortAymeric Lanore, Edouard Januel, Nathalie Bertille, et al.
Pageof 44